Mortality of women with polycystic ovary syndrome at long-term follow-up

Journal of Clinical Epidemiology

Volumn 51, Issue 7, 1998, Pages 581-586

  Pierpoint, T ^b   McKeigue, P M ^b   Isaacs, A J ^a   Wild, S H ^b   Jacobs, H S ^b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Cardiovascular disease; Insulin; Mortality; Polycystic ovary syndrome; Resistance

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; METABOLIC DISORDER; MORTALITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; UNITED KINGDOM; VASCULAR DISEASE;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; ODDS RATIO; POLYCYSTIC OVARY SYNDROME; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 2042548063     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(98)00035-3     Document Type: Article

References (32)

1. Polson D.W., Adams J., Wadsworth J., Franks S. Polycystic ovaries - A common finding in normal women. Lancet. 1:1988;870-872.
2. Clayton R.N., Ogden V., Hodgkinson J., Worswick L., Rodin D.A., Dyer S., Meade T.W. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol. 37:1992;127-134.
3. Farquhar C.M., Birdsall M., Manning P., Mitchell J.M., France J.T. The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust NZ J Obstet Gynaecol. 34:1994;67-72.
4. Dunaif A., Segal K.R., Futterwet W., Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1989;1165-1174.
5. Burghen G.A., Givens J.R., Kitabchi A.E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 50:1980;113-116.
6. Mattson L.A., Cullberg G., Hamberger L., Samsioe G., Silferstope G. Lipid metabolism in women with polycystic ovary syndrome. Possible implications for an increased risk of coronary heart disease Fertility and Sterility. 42:1984;579-584.
7. Lithell H., Nillius S.J., Bergh T., Selinus I. Metabolic profile in obese women with the polycystic ovary syndrome. Int J Obes. 11:1987;1-9.
8. Conway G.S., Agrawal R., Betteridge D.J., Jacobs H.S. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol. 37:1992;119-125.
9. Rebuffe-Scrive M., Cullberg G., Lundberg P.A., Lindstedt G., Bjorntorp P. Anthropometric variables and metabolism in polycystic ovarian disease. Horm Metab Res. 21:1989;391-397.
10. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
11. McKeigue P.M., Shah B., Marmot M.G. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 337:1991;382-386.
12. McKeigue P. Are women with polycystic ovary syndrome at special risk of coronary heart disease? Clin Endocrinol. 37:1992;117-118.
13. Wild R.A., Painter P.C., Coulson P.B., Carruth K.B., Ranney G.B. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 61:1985;946-951.
14. Dahlgren E., Janson P.O., Johansson S., Lapidus L., Oden A. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women Acta Obstet Gynecol Scand. 71:1992;599-604.
15. Talbott E., Guzick D., Clerici A., Berga S., Detre K., Weimer K., Kuller L. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb. 15:1995;821-826.
16. Dahlgren E., Johansson S., Lindstedt G., Knutsson F., Oden A., Janson P.O., Mattson L.A., Crona N., Lundberg P.A. Women with polycystic ovary syndrome wedge resected in 1956 to 1965. A long-term follow-up focusing on natural history and circulating hormones Fertility and Sterility. 57:1992;505-513.
17. Lerner D.J., Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes. A 26-year follow-up of the Framingham population Am Heart J. 111:1986;383-390.
18. Lapidus L., Bengtsson C., Larsson B., Pennert K., Rybo E., Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death. A 12 year follow up of participants in the population study of women in Gothenburg, Sweden BMJ. 289:1984;1257-1261.
19. Kratochwil A., Urban G., Friedrich F. Ultrasonic tomography of the ovaries. Ann Chir Gynaecol Fenn. 61:1972;211-214.
20. Swanson M., Sauerbrei E.E., Cooperberg P.L. Medical implications of ultrasonically detected polycystic ovaries. J Clin Ultrasound. 9:1981;219-222.
21. Donesky B.W., Adashi E.Y. Surgically induced ovulation in the polycystic ovary syndrome. Wedge resection in the age of laparoscopy Fertility and Sterility. 63:1995;439-463.
22. Office of Population Censuses and Surveys. Mortality statistics: Cause. Review of the Registrar General on Deaths by Cause, Sex and Age in England and Wales, 1986. Series DH2 no. 13. London: HM Stationery Office; 1988.
23. Conway G.S., Honour J.W., Jacobs H.S. Heterogeneity of polycystic ovary syndrome. Clinical, endocrine and ultrasound features in 556 cases Clin Endocrinol. 30:1989;459-470.
24. Goldblatt P. Mortality and alternative social classifications. In: Goldblatt P, Ed. Office of Population Censuses and Surveys Longitudinal Study: Mortality and Social Organization. Series LS no. 6, London: HM Stationery Office; 1994: 163-192.
25. Office of Population Censuses and Surveys Health Survey for England 1991. 1993;HM Stationery Office, London.
26. Isles C.G., Hole D.J., Hawthorne V.M., Lever A.F. Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey. Comparison with men Lancet. 339:1992;702-706.
27. Barnes R., Rosenfield R.L. The polycystic ovary syndrome. Pathogenesis and treatment Ann Intern Med. 110:1989;386-399.
28. Fuller J.H., Elford J., Goldblatt P., Adelstein A.M. Diabetes mortality. New light on an underestimated public health problem Diabetologia. 24:1983;336-341.
29. Dunaif A., Graf M., Mandeli J., Laumas V., Dobrjansky A. Characterization of groups of obese women with acanthosis nigricans, impaired glucose tolerance and/or hyperinsulinemia. J Clin Endocrinol Metab. 65:1987;499-507.
30. Graf M.J., Richards C.J., Brown V., Meissner L., Dunaif A. The independent effects of hyperandrogenaemia, hyperinsulinaemia and obesity in lipid and lipoprotein profiles in women. Clin Endocrinol. 33:1990;119-131.
31. Holte J., Bergh T., Berne C., Berglund L., Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 78:1994;1052-1058.
32. Meade T.W., Berra A. Hormone replacement therapy and cardiovascular disease. Br Med Bull. 48:1992;276-308.